Adrian Kilcoyne

Insider Reports History

Entity
Individual
Location
533 Airport Blvd., Suite 400, Burlingame, CA
Signature
/s/ Kyle Fletcher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adrian Kilcoyne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HUMANIGEN, INC Chief Medical Officer Stock Option (Right to Buy) 537K $2.43M $4.53 Jul 27, 2022 Direct
Celularity Inc Chief Medical Officer Class A Common Stock 1.12M $487K $0.43 Feb 17, 2024 Direct
Celularity Inc Chief Medical Officer Stock Option Grant (Right to Buy) 205K Feb 16, 2024 Direct

Insider Reports Filed by Adrian Kilcoyne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CELU Celularity Inc Feb 16, 2024 2 -$22.9K 4 Feb 21, 2024 Chief Medical Officer
CELU Celularity Inc Jul 14, 2023 1 $0 4 Jul 19, 2023 Chief Medical Officer
CELU Celularity Inc Feb 17, 2023 1 $0 4 Feb 22, 2023 Chief Medical Officer
CELU Celularity Inc Oct 3, 2022 1 $0 4 Oct 4, 2022 Executive Vice President, Chief Medical Officer
CELU Celularity Inc Sep 29, 2022 0 $0 3 Oct 4, 2022 Executive Vice President, Chief Medical Officer Exhibit 24 - Power of Attorney
HGEN HUMANIGEN, INC Jul 27, 2022 1 $0 4 Jul 29, 2022 Chief Medical Officer
HGEN HUMANIGEN, INC Mar 8, 2022 2 $31.6K 4 Mar 14, 2022 Chief Medical Officer
HGEN HUMANIGEN, INC Jan 12, 2022 1 $0 4 Jan 14, 2022 Chief Medical Officer
HGEN HUMANIGEN, INC Dec 31, 2021 1 $0 4 Jan 4, 2022 Chief Medical Officer
HGEN HUMANIGEN, INC Nov 23, 2021 1 -$26.6K 4 Nov 26, 2021 Chief Medical Officer
HGEN HUMANIGEN, INC Sep 30, 2021 1 $0 4 Oct 4, 2021 Chief Medical Officer